The following represents disclosure information provided by authors of this abstract. The Breast Cancer Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Comparison of locoregional recurrence in triple-negative and HER2-positive breast cancer subtype after breast-conserving therapy and modern systemic therapy.
C. Takita
No relevant relationships to disclose
I. M. Reis
No relevant relationships to disclose
F. Miao
No relevant relationships to disclose
K. E. LaFave
No relevant relationships to disclose
V. Gunaseelan
No relevant relationships to disclose
J. Hurley
No relevant relationships to disclose
O. E. Silva
No relevant relationships to disclose
E. Avisar
No relevant relationships to disclose
J. L. Wright
No relevant relationships to disclose